{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:29:36Z","timestamp":1790285376930,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized as a systemic multiorgan syndrome driven by low-grade inflammation. While epicardial adipose tissue (EAT) and skeletal muscle dysfunction are known contributors to exercise intolerance, their synergistic association remains undefined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>We aimed to investigate the \u201cAdipo-Muscular\u201d association\u2014the synergistic interplay between local cardiac inflammatory potential and peripheral muscle fatigability\u2014as a predictor of functional capacity in HFpEF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study enrolled 192 stable HFpEF patients and 200 age- and sex-matched healthy controls. EAT thickness was quantified via echocardiography. Peripheral muscle function was assessed through maximal isometric strength and handgrip endurance (maintenance time at 50% maximal voluntary contraction), the latter serving as a surrogate for Type I fiber oxidative capacity. Functional capacity was validated using the 6-Minute Pegboard Ring Test (6PBRT), specifically chosen for its sensitivity to upper extremity \u201cmyopenia\u201d (qualitative bioenergetic failure). A novel EAT-Endurance Index was calculated as: Index = ({EAT thickness [mm]} \/ {Handgrip endurance [sec]}) \u00d7100.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Despite comparable BMI between groups, HFpEF patients displayed significantly greater EAT thickness (5.46\u2009\u00b1\u20091.65 vs. 3.20\u2009\u00b1\u20091.03\u00a0mm,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). While maximal strength showed a moderate decline, handgrip endurance was profoundly compromised in HFpEF (48.48\u2009\u00b1\u200914.4 vs. 72.24\u2009\u00b1\u200912.1\u00a0s,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), representing a massive effect size (Cohen\u2019s d = -1.791). In multivariate analysis adjusting for age, sex, BMI, and major comorbidities (Hypertension, Diabetes, and Coronary Artery Disease), the EAT-Endurance Index emerged as the strongest independent predictor of impaired functional capacity (\u03b2\u2009=\u20090.385,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Sensitivity analysis confirmed this association was independent of glycemic status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified a distinct \u201cAdipo-Muscular\u201d phenotype in HFpEF, characterized by expanded epicardial fat and profound skeletal muscle fatigability. This association predicts functional decline independently of systemic obesity, maximal strength, and classic comorbidities. Targeting the interface between central adiposity and skeletal muscle mitochondrial function may offer novel therapeutic avenues for this challenging population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-05833-6","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:45:11Z","timestamp":1776843911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The \u201cAdipo-Muscular\u201d association in heart failure with preserved ejection fraction: synergistic impact of epicardial adipose tissue and skeletal muscle endurance on functional capacity"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7280-5137","authenticated-orcid":false,"given":"Ertan","family":"Aydin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0716-1109","authenticated-orcid":false,"given":"Habibe","family":"Durdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-8778","authenticated-orcid":false,"given":"Asli","family":"Vural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4731-0040","authenticated-orcid":false,"given":"Ceren","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-3248","authenticated-orcid":false,"given":"Devrim","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3543-2261","authenticated-orcid":false,"given":"Ulfat","family":"Bayraml\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9729-6391","authenticated-orcid":false,"given":"G\u00f6khan","family":"G\u00f6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"5833_CR1","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37:2315\u201381.","journal-title":"Eur Heart J"},{"key":"5833_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"5833_CR3","first-page":"636","volume":"6","author":"M Packer","year":"2018","unstructured":"Packer M. Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium. JACC Heart Fail. 2018;6:636\u201343.","journal-title":"JACC Heart Fail"},{"key":"5833_CR4","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.15420\/cfr.2021.04","volume":"7","author":"H Sorimachi","year":"2021","unstructured":"Sorimachi H, Obokata M, Omote K, et al. Pathophysiology of HFpEF: The role of Epicardial Adipose Tissue. Card Fail Rev. 2021;7:e13.","journal-title":"Card Fail Rev"},{"key":"5833_CR5","first-page":"47","volume":"2","author":"DW Kitzman","year":"2014","unstructured":"Kitzman DW, Brubaker PH, Morgan TM, et al. Exercise intolerance in heart failure with preserved ejection fraction: Gastric, cardiac, peripheral, or skeletal muscle? JACC Heart Fail. 2014;2:47\u201356.","journal-title":"JACC Heart Fail"},{"key":"5833_CR6","first-page":"820","volume":"132","author":"N Houstis","year":"2023","unstructured":"Houstis N, Rosenzweig A, Zweigerdt R. CD36 and the metabolic rescue of the failing heart. Circ Res. 2023;132:820\u20132.","journal-title":"Circ Res"},{"key":"5833_CR7","first-page":"4111","volume":"7","author":"T Bekfani","year":"2020","unstructured":"Bekfani T, Hamadanchi A, Seethaler B, et al. Muscle endurance in patients with heart failure. ESC Heart Fail. 2020;7:4111\u201321.","journal-title":"ESC Heart Fail"},{"key":"5833_CR8","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"key":"5833_CR9","first-page":"1","volume":"20","author":"E Zamora","year":"2023","unstructured":"Zamora E, Lupon J. Sarcopenia in Heart Failure. Curr Heart Fail Rep. 2023;20:1\u201310.","journal-title":"Curr Heart Fail Rep"},{"key":"5833_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","volume":"19","author":"G Iacobellis","year":"2022","unstructured":"Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19:593\u2013606.","journal-title":"Nat Rev Cardiol"},{"key":"5833_CR11","first-page":"1968","volume":"22","author":"M Packer","year":"2020","unstructured":"Packer M, Lamichhane P. Adipokines and heart failure. Eur J Heart Fail. 2020;22:1968\u201373.","journal-title":"Eur J Heart Fail"},{"key":"5833_CR12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","volume":"389","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod MN, Abildstr\u00f8m SZ, Borlaug BA, et al. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2023;389:1069\u201384.","journal-title":"N Engl J Med"},{"key":"5833_CR13","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385:1451\u201361.","journal-title":"N Engl J Med"},{"key":"5833_CR14","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0735-1097(23)02099-5","volume":"81","author":"JA Requena-Ib\u00e1\u00f1ez","year":"2023","unstructured":"Requena-Ib\u00e1\u00f1ez JA, Santos-Gallego CG, Rodriguez-Cordero A, et al. Effects of Empagliflozin on Epicardial Adipose Tissue in Patients with Heart Failure. J Am Coll Cardiol. 2023;81:1655\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"5833_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.mayocp.2016.11.001","volume":"92","author":"S Carbone","year":"2022","unstructured":"Carbone S, Lavie CJ, Arena R. Obesity and Heart Failure: Focus on the Obesity Paradox. Mayo Clin Proc. 2022;92:266\u201379.","journal-title":"Mayo Clin Proc"},{"key":"5833_CR16","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/dom.13788","volume":"21","author":"NR Pugliese","year":"2019","unstructured":"Pugliese NR, De Biase N, Mazzola RJ, et al. Epicardial adipose tissue and left ventricular function in type 2 diabetes. Diabetes Obes Metab. 2019;21:2115\u201324.","journal-title":"Diabetes Obes Metab"},{"key":"5833_CR17","first-page":"920","volume":"8","author":"VN Rao","year":"2020","unstructured":"Rao VN, Fudim M, Lowenstern A, et al. Epicardial Adipose Tissue and Exercise Capacity in Heart Failure. JACC Heart Fail. 2020;8:920\u201330.","journal-title":"JACC Heart Fail"},{"key":"5833_CR18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ejhf.2741","volume":"24","author":"G van Woerden","year":"2022","unstructured":"van Woerden G, Gorter TM, Westenbrink BD, et al. Epicardial fat and outcomes in heart failure. Eur J Heart Fail. 2022;24:331\u20139.","journal-title":"Eur J Heart Fail"},{"key":"5833_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fphys.2020.00043","volume":"11","author":"V Parisi","year":"2020","unstructured":"Parisi V, Petraglia L, D\u2019Esposito V, et al. Epicardial Adipose Tissue and Arrhythmogenic Risk. Front Physiol. 2020;11:43.","journal-title":"Front Physiol"},{"key":"5833_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.amjcard.2013.12.031","volume":"113","author":"MJ Haykowsky","year":"2014","unstructured":"Haykowsky MJ, Brubaker PH, Morgan TM, et al. Skeletal muscle composition and exercise tolerance in heart failure with preserved ejection fraction. Am J Cardiol. 2014;113:109\u201311.","journal-title":"Am J Cardiol"},{"key":"5833_CR21","first-page":"425","volume":"7","author":"DW Kitzman","year":"2014","unstructured":"Kitzman DW, Nicklas B, Kraus WE, et al. Skeletal muscle mass and exercise capacity in older heart failure patients with preserved ejection fraction. Circ Heart Fail. 2014;7:425\u201333.","journal-title":"Circ Heart Fail"},{"key":"5833_CR22","first-page":"478","volume":"5","author":"M Valero-Munoz","year":"2017","unstructured":"Valero-Munoz M, Backman JD, Sam F. Adipose Tissue Dysfunction and Heart Failure With Preserved Ejection Fraction: From Biomarkers to Mechanisms. JACC Heart Fail. 2017;5:478\u201389.","journal-title":"JACC Heart Fail"},{"key":"5833_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11:85\u201397.","journal-title":"Nat Rev Immunol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05833-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05833-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05833-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:57:31Z","timestamp":1782885451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05833-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5833"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05833-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of Giresun Training and Research Hospital (Date: 04\/02\/2026 \/ Protocol Code: 2026\/21).Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"553"}}